Roberto Ortiz
机构：Orlando Health, Hospital Clínico Universitario Lozano Blesa · ORCID：0009-0006-1036-3085
发表论文 95 篇 · 总被引 4362 次 · h-index 12
代表论文
- Efficacy and Safety Outcomes in Adults Initiating Dolutegravir/Lamivudine With High Viral Load in the GEMINI-1/-2 and STAT Trials (2025 · Open Forum Infectious Diseases · 被引 2)
- P-1424. Patient Experiences at Month 6 after Initiation of Cabotegravir Long-Acting (CAB LA) for PrEP in the First Male Gender Concordant Implementation Science Trial (PILLAR) in the US (2025 · Open Forum Infectious Diseases · 被引 2)
- Virological Failure Associated with the Concomitant Use of Red Yeast Rice and Dolutegravir/Abacavir/Lamivudine in an HIV-1 Patient: A Case Report (2026 · Journal of Pharmaceutical Care)
- Supplementary Figure S4 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer (2025)
- Supplementary Methods from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer (2025)
- Supplementary Figure S6 from Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer (2025)